Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease

US Patent 11701341 · Granted Jul 18, 2023

Estimated economic value: $3,198,000

Assignee

Inventors

View full patent text on Google Patents →